McKesson stock: Leerink Partners raises target for McKesson stock to USD 1,070

Published on 10/16/2026 at 16:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2027 first-quarter revenue rose 7.70 percent to USD 105.38 billion. McKesson stock costs EUR 890.90 on October 16, 2026 at Lang & Schwarz.

Analyst view and market measures

Leerink Partners lifted its McKesson target to USD 1,070 on October 7, 2026.
Fiscal 2027 first-quarter revenue rose 7.70 percent to USD 105.38 billion.
McKesson stock costs EUR 890.90 at Lang & Schwarz on October 16, 2026 at 4:40 p.m. CEST.
McKesson had a USD 116.9 billion market capitalization on October 16, 2026.

Draufsicht auf Aktienzertifikat, ISIN-Karte, Stethoskop und Tabletten auf Holztisch — Flatlay-Arrangement mit Aktienzertifikat und ISIN-Karte US58155Q1031 illustriert eine Investition in McKesson Corporation im Gesundheitswesen heute, Illustration mit AI erstellt.

Leerink Partners raised its McKesson target from USD 1,030.00 to USD 1,070.00 on October 7, 2026, while keeping an outperform rating, according to MarketBeat. Against McKesson's USD 1,002.25 NYSE quote at 10:53 a.m. ET on October 16, 2026, the target stood 6.76 percent higher. McKesson stock was trading at EUR 890.90 at Lang & Schwarz on October 16, 2026 at 4:40 p.m. CEST.

Revenue reached USD 105.38 billion

McKesson's first fiscal quarter of 2027 ended June 30, 2026, with revenue of USD 105.38 billion and net income attributable to common shareholders of USD 614.0 million. The quarter's revenue increased 7.70 percent from the year-earlier period, while diluted earnings per share came to USD 5.15. MarketBeat also reported adjusted quarterly earnings per share of USD 9.93 and revenue of USD 105.38 billion against consensus revenue of USD 103.88 billion.

McKesson stock near its yearly high

The NYSE quote stood within McKesson's USD 723.68 to USD 1,014.99 52-week range on October 16, 2026. At USD 1,002.25, the stock was 1.25 percent below the high. Trading volume was 135,229 shares against an average volume of 904,729 shares, giving the session a lighter turnover profile than the recent average.

Valuation and shareholder return

McKesson's market capitalization was USD 116.9 billion and its price-to-earnings ratio was 26.82 on October 16, 2026. The next earnings date was not included in the dated company information reviewed for this report. The company had paid a quarterly dividend of USD 0.94 per share on October 1, 2026, after raising it from USD 0.82, according to MarketBeat.

Comparison with peers

McKesson (NYSE, USD): P/E 26.82, market capitalization USD 116.9 billion

Cardinal Health (NYSE, USD): plus 0.24 percent, P/E 35.11, market capitalization USD 58.9 billion

Cencora (NYSE, USD): minus 0.23 percent, P/E 25.28, market capitalization USD 65.0 billion

Price and trading position

McKesson's euro quotation was EUR 890.90 at Lang & Schwarz on October 16, 2026 at 4:40 p.m. CEST. The primary-market quote was USD 1,002.25 on the NYSE at 10:53 a.m. ET on the same date, keeping the home-market view separate from the euro quotation. The further course of trading is shown by the continuously updated real-time quote of McKesson stock.